Cardiovascular activity of WIN 65579, a novel inhibitor of cyclic GMP phosphodiesterase 5SILVER, P. J; PAGANI, E. D; DUNDORE, R. L et al.European journal of pharmacology. 1998, Vol 349, Num 2-3, pp 263-268, issn 0014-2999Article

Imidazotriazinose inhibitors of the Ca²⁺ -calmodulin sensitive phosphodiesterase (PDEI)¹HLASTA, D. J; BODE, D. C; COURT, J. J et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 1, pp 89-94, issn 0960-894XArticle

Cellular distribution of phosphodiesterase isoforms in rat cardiac tissueBODE, D. C; KANTER, J. R; BRUNTON, L. L et al.Circulation research. 1991, Vol 68, Num 4, pp 1070-1079, issn 0009-7330Article

Cytochrome-P450 induction and conjugated metabolism in primary human hepatocytes after cryopreservationRUEGG, C. E; SILBER, P. M; MUGHAL, R. A et al.In vitro toxicology. 1997, Vol 10, Num 2, pp 217-222, issn 0888-319XArticle

Enrichment and analysis of desmosine and isodesmosine in biological fluidsCUMISKEY, W. R; PAGANI, E. D; BODE, D. C et al.Journal of chromatography. B, Biomedical applications. 1995, Vol 668, Num 2, pp 199-207Article

Novel and potent adenosine 3',5'-cyclic phosphate phosphodiesterase III inhibitors : thiazolo[4,5-b][1,6]naphthyridin-2-onesBALDEV SINGH; BACON, E. R; SILVER, P. J et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 14, pp 2546-2550, issn 0022-2623Article

Relationship between ethanol-induced alterations in fluorescence anisotropy and adenylate cyclase activityRABIN, R. A; BODE, D. C; MOLINOFF, P. B et al.Biochemical pharmacology. 1986, Vol 35, Num 14, pp 2331-2335, issn 0006-2952Article

Zaprinast, but not dipyridamole, reverses hemodynamic tolerance to nitroglycerin in vivoDE GARAVILLA, L; PAGANI, E. D; BUCHHOLZ, R. A et al.European journal of pharmacology. 1996, Vol 313, Num 1-2, pp 89-96, issn 0014-2999Article

Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epitheliumBODE, D. C; HAMEL, L. T; WAC, M. B et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 267, Num 3, pp 1286-1291, issn 0022-3565Article

Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of ratsDUNDORE, R. L; CLAS, D. M; WHEELER, L. T et al.European journal of pharmacology. 1993, Vol 249, Num 3, pp 293-297, issn 0014-2999Article

Novel cAMP PDE III inhibitors : 1,6-Naphthyridin-2(1H)-onesBALDEV SINGH; LESHER, G. Y; PLUNCKET, K. C et al.Journal of medicinal chemistry (Print). 1992, Vol 35, Num 26, pp 4858-4865, issn 0022-2623Article

Relationship between ethanol-induced alterations in fluorescence anisotropy and adenylate cyclase activityRABIN, R. A; BODE, D. C; MOLINOFF, P. B et al.Biochemical pharmacology. 1986, Vol 35, Num 14, pp 2331-2335, issn 0006-2952Article

Species-dependent pharmacodynamic effects of the selective low K_m cyclic AMP phosphodiesterase III inhibitors WIN 58993 and WIN 62005DUNDORE, R. L; PAGANI, E. D; BODE, D. C et al.Journal of cardiovascular pharmacology. 1995, Vol 25, Num 1, pp 14-21, issn 0160-2446Article

Adenosine 3',5'-cyclic monophosphate attenuates neutrophil-mediated increase in endothelial permeabilitySIFLINGER-BIRNBOIM, A; BODE, D. C; MALIK, A. B et al.American journal of physiology. Heart and circulatory physiology. 1993, Vol 33, Num 2, pp H370-H375, issn 0363-6135Article

Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase systemBODE, D. C; MOLINOFF, P. B.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 3, pp 1040-1047, issn 0022-3565Article

Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase systemBODE, D. C; MOLINOFF, P. B.The Journal of pharmacology and experimental therapeutics. 1988, Vol 246, Num 3, pp 1040-1047, issn 0022-3565Article

Differential effects of cytosolic modulators of fluoride-stimulated adenylate cyclase activity in striatum and cerebral cortexRABIN, R. A; BODE, D. C; MOLINOFF, P. B et al.Alcohol and drug research. 1985, Vol 6, Num 6, pp 379-386, issn 0883-1386Article